145 related articles for article (PubMed ID: 17376011)
1. Steroid hormone receptor gene polymorphisms and osteoporosis: a pharmacogenomic review.
Gennari L; De Paola V; Merlotti D; Martini G; Nuti R
Expert Opin Pharmacother; 2007 Apr; 8(5):537-53. PubMed ID: 17376011
[TBL] [Abstract][Full Text] [Related]
2. Update on the pharmacogenetics of the vitamin D receptor and osteoporosis.
Gennari L; Merlotti D; De Paola V; Martini G; Nuti R
Pharmacogenomics; 2009 Mar; 10(3):417-33. PubMed ID: 19290791
[TBL] [Abstract][Full Text] [Related]
3. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes].
Brodowska A
Ann Acad Med Stetin; 2003; 49():111-30. PubMed ID: 15552843
[TBL] [Abstract][Full Text] [Related]
4. Genetic control of bone density and turnover: role of the collagen 1alpha1, estrogen receptor, and vitamin D receptor genes.
Brown MA; Haughton MA; Grant SF; Gunnell AS; Henderson NK; Eisman JA
J Bone Miner Res; 2001 Apr; 16(4):758-64. PubMed ID: 11316004
[TBL] [Abstract][Full Text] [Related]
5. Management of osteoporosis with calcitriol in elderly Chinese patients: a systematic review.
Liao RX; Yu M; Jiang Y; Xia W
Clin Interv Aging; 2014; 9():515-26. PubMed ID: 24729692
[TBL] [Abstract][Full Text] [Related]
6. Relation of vitamin D receptor FokI start codon polymorphism to bone mineral density and occurrence of osteoporosis in postmenopausal women in Taiwan.
Chen HY; Chen WC; Hsu CD; Tsai FJ; Tsai CH
Acta Obstet Gynecol Scand; 2002 Feb; 81(2):93-8. PubMed ID: 11942896
[TBL] [Abstract][Full Text] [Related]
7. Genetics of osteoporosis: role of steroid hormone receptor gene polymorphisms.
Gennari L; Becherini L; Falchetti A; Masi L; Massart F; Brandi ML
J Steroid Biochem Mol Biol; 2002 May; 81(1):1-24. PubMed ID: 12127038
[TBL] [Abstract][Full Text] [Related]
8. Genetics and pharmacogenetics of osteoporosis.
Carbonell Sala S; Masi L; Marini F; Del Monte F; Falchetti A; Franceschelli F; Brandi ML
J Endocrinol Invest; 2005; 28(10 Suppl):2-7. PubMed ID: 16550715
[TBL] [Abstract][Full Text] [Related]
9. The Sp1 COLIA1 gene polymorphism, and not vitamin D receptor or estrogen receptor gene polymorphisms, determines bone mineral density in postmenopausal Greek women.
Efstathiadou Z; Kranas V; Ioannidis JP; Georgiou I; Tsatsoulis A
Osteoporos Int; 2001; 12(4):326-31. PubMed ID: 11420783
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms of the VDR, ER and COLIA1 genes and osteoporotic hip fracture in elderly postmenopausal women.
Aerssens J; Dequeker J; Peeters J; Breemans S; Broos P; Boonen S
Osteoporos Int; 2000; 11(7):583-91. PubMed ID: 11069192
[TBL] [Abstract][Full Text] [Related]
11. The genetics of osteoporosis.
Roux S
Joint Bone Spine; 2001 Dec; 68(6):482-6. PubMed ID: 11808984
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D in the treatment of osteoporosis revisited.
Fujita T
Proc Soc Exp Biol Med; 1996 Jun; 212(2):110-5. PubMed ID: 8650247
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor alpha gene polymorphisms are associated with changes in bone remodeling markers and treatment response to estrogen.
Rapuri PB; Gallagher JC; Knezetic JA; Haynatzka V
Maturitas; 2006 Mar; 53(4):371-9. PubMed ID: 16139450
[TBL] [Abstract][Full Text] [Related]
14. BsmI vitamin D receptor genotypes influence the efficacy of antiresorptive treatments in postmenopausal osteoporotic women. A 1-year multicenter, randomized and controlled trial.
Palomba S; Orio F; Russo T; Falbo A; Tolino A; Manguso F; Nunziata V; Mastrantonio P; Lombardi G; Zullo F
Osteoporos Int; 2005 Aug; 16(8):943-52. PubMed ID: 15739035
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D receptor, oestrogen receptor-alpha and calcium-sensing receptor genotypes, bone mineral density and biochemical markers in Paget's disease of bone.
Donáth J; Speer G; Poór G; Gergely P; Tabák A; Lakatos P
Rheumatology (Oxford); 2004 Jun; 43(6):692-5. PubMed ID: 14997007
[TBL] [Abstract][Full Text] [Related]
16. [Genetic risk factors of osteoporosis--vitamin D receptor gene polymorphism].
Seremak-Mrozikiewicz A; Drews K
Ginekol Pol; 2004 May; 75(5):404-11. PubMed ID: 15524415
[TBL] [Abstract][Full Text] [Related]
17. The role of vitamin D receptor gene polymorphisms in the bone mineral density of Greek postmenopausal women with low calcium intake.
Stathopoulou MG; Dedoussis GV; Trovas G; Theodoraki EV; Katsalira A; Dontas IA; Hammond N; Deloukas P; Lyritis GP
J Nutr Biochem; 2011 Aug; 22(8):752-7. PubMed ID: 21115334
[TBL] [Abstract][Full Text] [Related]
18. Recent progress in understanding the genetic susceptibility to osteoporosis.
Zmuda JM; Cauley JA; Ferrell RE
Genet Epidemiol; 1999; 16(4):356-67. PubMed ID: 10207717
[TBL] [Abstract][Full Text] [Related]
19. Polymorphism of vitamin D3 receptor and its relation to mineral bone density in perimenopausal women.
Boroń D; Kamiński A; Kotrych D; Bogacz A; Uzar I; Mrozikiewicz PM; Czerny B
Osteoporos Int; 2015 Mar; 26(3):1045-52. PubMed ID: 25407264
[TBL] [Abstract][Full Text] [Related]
20. Association of vitamin D and estrogen receptor gene polymorphism with the effect of hormone replacement therapy on bone mineral density in Japanese women.
Kurabayashi T; Tomita M; Matsushita H; Yahata T; Honda A; Takakuwa K; Tanaka K
Am J Obstet Gynecol; 1999 May; 180(5):1115-20. PubMed ID: 10329864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
